- Patent Title: Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus
-
Application No.: US16512194Application Date: 2019-07-15
-
Publication No.: US10557149B1Publication Date: 2020-02-11
- Inventor: Qizhao Wang
- Applicant: Vigene Biosciences Inc.
- Applicant Address: US MD Rockville
- Assignee: Vigene Biosciences, Inc.
- Current Assignee: Vigene Biosciences, Inc.
- Current Assignee Address: US MD Rockville
- Agency: AuerbachSchrot LLC
- Agent Jeffrey I. Auerbach
- Main IPC: C12N15/86
- IPC: C12N15/86 ; C12N5/071 ; C12N5/07

Abstract:
The present invention is directed to recombinantly-modified adeno-associated virus (AAV) helper vectors that are capable of increasing the packaging efficiency of recombinantly-modified adeno-associated virus (rAAV) and their use to improve the packaging efficiency of such rAAV. The present invention is particularly directed to recombinantly-modified adeno-associated virus (AAV) helper vectors that have been further modified to replace (or augment) the P5 and/or P40 promoter sequences that are natively associated with the Rep proteins encoded by such rAAV with AAV P5 and/or P40 promoters that are associated with the Rep proteins of an rAAV of different serotype. The use of such substitute or additional promoter sequences causes increased production of recombinantly-modified adeno-associated virus.
Information query
IPC分类: